Francesco De Rubertis, Medicxi co-founder

July 27, 2023 03:00 AM EDTUpdated 04:03 AM

The veteran crew at Medicxi is back with a new $400M fund and an upbeat assessment of what's coming

No two biotech VC groups are exactly the same.

Each has its own specialty; each has its ideas about assets and platforms. And you can …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

US warns drugmakers against misrepresenting cost of imported products

Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontent

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?